Vd. Shortridge et al., NOVEL MECHANISM OF MACROLIDE RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE, Diagnostic microbiology and infectious disease, 26(2), 1996, pp. 73-78
The mechanism of macrolide resistance was examined in 73 clinical isol
ates of Streptococcus pneumoniae. Two distinct resistance phenotypes w
ere observed: high-level macrolides-lincosamides-streptogramin B (MLS)
resistance and low-level macrolide resistance with lincosamide suscep
tibility. High-level MLS resistance was associated with the presence o
f ermAM. Strains with the low-level resistant phenotype (novel) were n
egative for ermA, ermC, ermAM, ereA, ereB and msrA by polymerase chain
reaction (PCR) amplification with gene-specific primers. Ribosomes is
olated from novel strains bound the same amount of [C-14]-erythromycin
as ribosomes from sensitive strains. These novel strains also did not
inactivate the macrolide. The novel mechanism was found in 41% of the
erythromycin resistant S. pneumoniae examined. (C) 1996 Elsevier Scie
nce Inc.